# Final Production Go-Live Authorization Evidence Pack

**Package:** Final Production Go-Live Authorization Evidence Pack  
**Baseline:** After Production Pilot Evidence Execution Pack  
**Status:** Documentation/evidence-control authorization package; production-wide go-live requires named human authorization

## 1. Purpose

The Final Production Go-Live Authorization Evidence Pack converts the completed production pilot evidence baseline into a controlled final authorization package for production-wide go-live decisioning.

This package is intentionally documentation/evidence-control only. Final production go-live authorization does not add runtime APIs, database migrations, formulas, AI behavior, n8n behavior, object-storage behavior, approval behavior, report issue behavior, work-order behavior, external CMMS integration, full API 579, full API 581, 3D processing, or copied API/API-ASME formulas.

Final production go-live authorization is the last human release decision before production-wide enablement. It is not an automated deployment, not an AI decision, not an n8n workflow decision, and not a service-actor signoff.

## 2. Required Final Go-Live Evidence

| Evidence ID | Evidence area | Required artifact | Owner | Exit condition |
|---|---|---|---|---|
| GOLIVE-001 | Release baseline confirmation | Final release tag, commit SHA, branch, PR, artifact identifier, and clean working tree evidence | Release Manager / DevOps | Final artifact traces to approved release baseline |
| GOLIVE-002 | Production pilot closure | Pilot completion decision, defects disposition, business validation, operational readiness, and KPI evidence | Product Owner / Pilot Owner | Pilot is closed or no-go is documented |
| GOLIVE-003 | Phase 5 closure confirmation | Phase 5 final closure pack and evidence archive reference | Release Manager | P5-1 through P5-6 closure remains attached and reconciled |
| GOLIVE-004 | Security and secrets signoff | P5-1 evidence, residual-risk disposition, and named human security approval | Security Owner | No blocker security gap remains without approved risk acceptance |
| GOLIVE-005 | Deployment and environment signoff | P5-2 evidence, final environment configuration review, migration/seed rehearsal, smoke test, and rollback evidence | DevOps / Lead Engineer | Production environment is approved for cutover |
| GOLIVE-006 | Observability and incident readiness signoff | P5-3 monitoring, alert routing, incident response, and hypercare readiness evidence | Operations / Hypercare Owner | Monitoring and incident response are active and owned |
| GOLIVE-007 | Backup, restore, and DR signoff | P5-4 backup/restore/DR evidence, RPO/RTO, and escalation proof | DevOps / Operations | Recovery readiness is approved or explicitly risk-accepted |
| GOLIVE-008 | Performance, scale, and lifecycle signoff | P5-5 performance, capacity, retention, lifecycle, and accepted-risk evidence | Lead Engineer / Product Owner | Performance and data lifecycle risk is accepted by humans |
| GOLIVE-009 | Integration readiness signoff | P5-6 integration boundary, CMMS fallback/cutover, notification, replay, and service-account evidence | Integration Owner / DevOps | Integration path and fallback are authorized |
| GOLIVE-010 | Cutover and rollback authorization | Cutover plan, rollback owner, communication route, decision window, and rollback trigger criteria | Release Manager / DevOps / Operations | Cutover may proceed only within approved window and rollback path |
| GOLIVE-011 | Final residual-risk business acceptance | Consolidated residual risks, go/no-go recommendation, business impact, and executive acceptance | Product Owner / Business Sponsor | Residual risk is accepted or production-wide go-live is blocked |
| GOLIVE-012 | Final human production go-live authorization | Named human approval or no-go record with date, role, evidence archive, and authorization scope | Authorized Go-Live Approver | Final production go-live is approved or rejected by named humans only |

## 3. Evidence Safety Rule

Do not paste secrets, JWTs, passwords, object-storage keys, signed URLs, production credentials, database connection strings with passwords, private keys, webhook secrets, CMMS credentials, confidential client evidence, vulnerability exploit details, or irreversible production cutover credentials into go-live documents. Use redacted placeholders and attach sensitive evidence only in approved secure evidence storage.

## 4. Final Human Authorization Rule

Final production go-live authorization must be reviewed and signed by named humans. Automated deployment tools, AI, n8n, service actors, monitoring systems, and CI jobs may generate evidence, but they cannot approve go-live, accept final residual risk, waive missing evidence, authorize cutover, authorize rollback closure, or sign production-wide release approval.

Required human roles:

- Authorized Go-Live Approver;
- Product Owner / Business Sponsor;
- Release Manager;
- Lead Engineer;
- Security Owner;
- IT Admin / DevOps;
- Operations / Hypercare Owner;
- Integration Owner, if external integration is in scope.

## 5. No-Go Conditions

A final production go-live no-go must be recorded if any of the following remain true:

- final release tag, commit SHA, artifact provenance, or evidence archive location is missing;
- production pilot completion evidence is missing or unresolved blocker defects remain;
- Phase 5 closure evidence is incomplete or not reconciled;
- security, deployment/environment, observability, backup/restore/DR, performance/lifecycle, or integration signoff is missing;
- real secrets, object-storage keys, signed URLs, production credentials, webhook secrets, or CMMS credentials are committed or pasted into evidence records;
- n8n has direct PostgreSQL write access or direct database credentials;
- AI/n8n/service actors can approve final production go-live, accept final residual risks, authorize cutover, waive missing evidence, close go-live gaps, or sign final production authorization;
- rollback owner, rollback command path, rollback trigger criteria, or communication path is missing;
- hypercare activation owner, cadence, monitoring route, or incident escalation path is missing;
- full API 579, full API 581, or copied API/API-ASME formulas are treated as implemented when they remain controlled exclusions.

## 6. Completion Rule

Final production go-live authorization is complete only when `GOLIVE-001` through `GOLIVE-012` are attached, reviewed, and referenced from the release evidence register or explicitly marked not applicable with rationale and named human approval.

Production-wide go-live may proceed only after `GOLIVE-012` is signed by a named human authorized go-live approver. AI/n8n/service actors cannot approve final production go-live.

AIM remains the system of record. n8n remains orchestration-only.


## 7. Exact Human-Only Authorization Markers

AI/n8n/service actors cannot approve final production go-live.
AI/n8n/service actors cannot accept final residual risks.
AI/n8n/service actors cannot authorize cutover.
AI/n8n/service actors cannot approve hypercare activation.
AI/n8n/service actors cannot close go-live gaps.
AI/n8n/service actors cannot sign final production authorization.
